Gemphire Therapeutics | 8-K: Current report
Gemphire Therapeutics | 8-K: Current report
Gemphire Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Gemphire Therapeutics | S-8 POS: S-8 POS
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Unlock the Full List